Loading…
Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 9,062 other HR bills in the 116th — cohort avg 39d
Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020 This bill allows the use of hemp, cannabidiol (i.e., CBD) derived from hemp, or any other ingredient derived from hemp in a dietary supplement, provided that the supplement meets other applicable requirements.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (15)
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2021 · second_quarter · Agriculture
Issues related to hemp-based cannabidiol (CBD); Food and Drug Administration activity to set standards for food and dietary supplements containing hemp-based CBD; H.R. 5587, a bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances; H.R. 8179, The Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020.
Client expense: Not reported · Firm income: $50,000
Government targets: SENATE
2020 · fourth_quarter · Agriculture
Cannabis and agricultural issues including: Support passage of H.R. 3883 - MORE Act Support passage of H.R. 2093 - STATES Act Support passage of H.R. 8179 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act Support the inclusion of above legislation in omnibus and coronavirus relief packages: H.R. 8900 and H.R. 748
Client expense: Not reported · Firm income: $45,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Consumer Issues/Safety/Products
Policy initiatives on hemp-derived cannabidiol (CBD), supporting actions that will lead to a legal and regulatory pathway to market for hemp-derived CBD products, pertaining to dietary supplements. H.R. 8179 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020. H.R. 5587 - A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances. S. 2895 - SARMs Control Act of 2019, A bill that would give authority to the Attorney General to schedule SARMs as a controlled substance.
Client expense: $60,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE, Treasury, Dept of
2020 · fourth_quarter · Agriculture
Trade agreements and the treatment of tobacco; issues affecting tobacco; industrial hemp and cannabis issues; FDA treatment of tobacco and hemp, H.R.8179.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Government Issues
HR 8179 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020; provisions related to the federal regulation of CBD S 2032 Cannabidiol and Marihuana Research Expansion Act FDA Cannabidiol Enforcement Policy: Draft Guidance for Industry
Client expense: $40,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Food Industry (safety, labeling, etc.)
| Democratic |
| ME |
| Collin C. Peterson | Democratic | MN |
| David J. Trone | Democratic | MD |
| David P. Joyce | Republican | OH |
| Denver Riggleman | Republican | VA |
| Don Bacon | Republican | NE |
| Don Young | Republican | AK |
| Earl Blumenauer | Democratic | OR |
| Glenn Grothman | Republican | WI |
| H. Morgan Griffith | Republican | VA |
| James Comer | Republican | KY |
| Jimmy Panetta | Democratic | CA |
| John A. Yarmuth | Democratic | KY |
| Mark Pocan | Democratic | WI |
| Matt Gaetz | Republican | FL |
| Mike Rogers | Republican | AL |
| Peter A. DeFazio | Democratic | OR |
| Rodney Davis | Republican | IL |
| Ron Kind | Democratic | WI |
| Ruben Gallego | Democratic | AZ |
| Salud O. Carbajal | Democratic | CA |
| Sean Patrick Maloney | Democratic | NY |
| Suzanne Bonamici | Democratic | OR |
| Tim Ryan | Democratic | OH |
| Tony Cárdenas | Democratic | CA |
| Tulsi Gabbard | Democratic | HI |
Canabidiol (CBD) product regulation H.R. 8179, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020 Food recall traceability FDA's "Blueprint for New Era in Food Safety"
Client expense: $197,171 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), Federal Motor Carrier Safety Administration, Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Occupational Safety & Health Administration (OSHA), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2020 · fourth_quarter · Food Industry (safety, labeling, etc.)
FDA regulations and legislation affecting dietary supplements, medical foods and other natural products; regulations and legislation related to foods and dietary supplements containing CBD; Coronavirus impact and response; H.R.5587, To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances; H.R.8179, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020; FY2021 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (H.R.7610), FY2021 Consolidated Appropriations Act (H.R.7608); Implementation of H.R.6201, Families First Coronavirus Response Act (P.L.116-127); Implementation of H.R.748, CARES Act (P.L.116-136); H.R.6800, The Heroes Act; Implementation of H.R.266, Paycheck Protection Program and Health Care Enhancement Act (P.L.116-139); H.R.8337, Continuing Appropriations Act, 2021 and Other Extensions Act; H.R.133, Making consolidated appropriations for the fiscal year ending September 30, 2021, providing coronavirus emergency response and relief, and for other purposes (P.L.116-260).
Client expense: Not reported · Firm income: $50,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Agriculture
Issues related to hemp-based cannabidiol (CBD); Food and Drug Administration activity to set standards for food and dietary supplements containing hemp-based CBD; H.R. 5587, a bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances; H.R. 8179, The Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
Issues related to hemp-based cannabidiol (CBD); Food and Drug Administration activity to set standards for food and dietary supplements containing hemp-based CBD; H.R. 5587, a bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances; H.R. 8179, The Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Banking
Safe Banking Act, Cannabis and Hemp agricultural issues; MORE Act, HR8179
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Pharmacy
Pseudoephedrine -- Potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient and oppose PSE restrictions such as a prescription requirement (no bill number). Mandatory recall authority of the FDA Supporting a process within FDA that ensures clarity and timely outcomes for the FDA, applicants and stakeholders, as well as utilizing existing technologies to further streamline the prescription-to-nonprescription switch application process without changing the existing clear distinction between prescription and nonprescription medicines. H.R.3164 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020 S.930 - Allowing Greater Access to Safe and Effective Contraception Act S.1847/H.R. 3296 - Affordability is Access Act S.2522 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020 H.R.6058 - SHOP SAFE Act of 2020 S.3431 - INFORM Consumers Act Legislation to increase domestic production of pharmaceuticals and the domestic supply chain. H.R. 6395 - National Defense Authorization Act for Fiscal Year 2021 S.4049 - National Defense Authorization Act for Fiscal Year 2021 HR 8179 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020
Client expense: $146,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of, Vice President of the U.S.
2020 · fourth_quarter · Health Issues
Monitor the following: H.R.8179, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020, generally H.R.7614, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021, Hemp-Derived Cannabidiol (CBD) regulations Public Law 116-260, Consolidated Appropriations Act, 2021, Division H, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021, Hemp-Derived Cannabidiol (CBD) regulations
Client expense: Not reported · Firm income: $30,000
2020 · fourth_quarter · Food Industry (safety, labeling, etc.)
Monitor the following: Hemp-Derived Cannabidiol (CBD) regulations H.R.8179, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020, generally S.4463, A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses, FSA and HSA, Dietary supplement related issues Regulatory enforcement of dietary supplements
Client expense: Not reported · Firm income: $20,000
2020 · fourth_quarter · Alcohol and Drug Abuse
H.R. 1595 - SAFE Banking Act of 2019 (Ed Perlmutter, D-CO-7) H.R.1119 - To amend the Controlled Substances Act to reduce the gap between Federal and State marijuana policy, and for other purposes (Earl Blumenauer, D-OR-3) H.R.2012 - To amend the Controlled Substances Act to provide that Federal law shall not preempt State law (Diana DeGette, D-CO-1) S.2400 - A bill to promote cannabis research, and for other purposes (Dick Durbin, D-IL) H.R.3884 - Marijuana Opportunity Reinvestment and Expungement Act of 2019 (Jerrold Nadler, D-NY-10) H.R.3884 - To decriminalize and deschedule cannabis, to provide for reinvestment in certain persons adversely impacted by the War on Drugs, to provide for expungement of certain cannabis offenses, and for other purposes (Jerrold Nadler, D-NY-10) oSenate version introduced by Kamala Harris, S.2227 H.R.3797 - To amend the Controlled Substances Act to make marijuana accessible for use by qualified marijuana researchers for medical purposes, and for other purposes (Earl Blumenauer, D-OR-3) H.R.4322 - Expanding Cannabis Research and Information Act (Donna Shalala, D-FL-27) H.R.4323 - Marijuana 1-to-3 Act of 2019 - To provide for the rescheduling of marijuana into schedule III of the Controlled Substances Act (Gregory Steube, R-FL-17) S.2979 - A bill to improve drug testing for transportation-related activities (Roger Wicker, R-MS) S.3070 - A bill to modify reporting requirements under the Controlled Substances Act (Dianne Feinstein, D-CA) S.4386 - A bill to decriminalize and reschedule cannabis, to provide for the regulation of cannabis and cannabis products to protect public health and safety, and for other purposes (Tina Smith, D-MN) H.R.8179 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020 (Kurt Schrader, D-OR-5) H.R.8732 - To modify reporting requirements under the Controlled Substances Act (Kathy Castor, D-FL-14)
Client expense: $470,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
2020 · fourth_quarter · Health Issues
issues relating to the approval of cannabinoids in supplements and food. HR 8179.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Food Industry (safety, labeling, etc.)
H.R. 7160. FY2021 Agriculture and Related Agencies Appropriations Act. Specifically regarding adequate Food and Drug Administration funding for regulation of dietary supplements and oversight of CBD products> Support for mandatory dietary supplement product registry. (no legislation) Support for regulatory pathway for quality hemp-derived products. H.R. 8179 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020
Client expense: Not reported · Firm income: $40,000
2020 · fourth_quarter · Agriculture
H.R. 7160. FY2021 Agriculture and Related Agencies Appropriations Act. Specifically regarding adequate Food and Drug Administration funding for regulation of dietary supplements and oversight of CBD products> Support for mandatory dietary supplement product registry. (no legislation) Support for regulatory pathway for quality hemp-derived products. H.R. 8179 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020
Client expense: Not reported · Firm income: $40,000
2020 · fourth_quarter · Agriculture
Support for regulatory pathway for quality hemp-derived products. H.R. 8179, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020 Support for adequate regulation of dietary supplements. (no specific bill)
Client expense: Not reported · Firm income: $10,000
2020 · fourth_quarter · Food Industry (safety, labeling, etc.)
Support for regulatory pathway for quality hemp-derived products. H.R. 8179, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020 Support for adequate regulation of dietary supplements. (no specific bill)
Client expense: Not reported · Firm income: $10,000
2020 · fourth_quarter · Food Industry (safety, labeling, etc.)
H.R. 8179, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020, a bill to to make hemp, cannabidiol derived from hemp, and any other ingredient derived from hemp lawful for use under the Federal Food, Drug, and Cosmetic Act as a dietary ingredient in a dietary supplement; all provisions relating to dietary supplements
Client expense: $70,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Agriculture
Cannabis and agricultural issues including: Support passage of H.R. 3883 - MORE Act Support passage of H.R. 2093 - STATES Act Support passage of H.R. 8179 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act
Client expense: Not reported · Firm income: $45,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Food Industry (safety, labeling, etc.)
FDA regulations and legislation affecting dietary supplements, medical foods and other natural products; regulations and legislation related to foods and dietary supplements containing CBD; Coronavirus impact and response; H.R.5587, To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances; H.R.8179, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020; FY2021 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (H.R.7610), FY2021 Consolidated Appropriations Act (H.R.7608); Implementation of H.R.6201, Families First Coronavirus Response Act (P.L.116-127); Implementation of H.R.748, CARES Act (P.L.116-136); H.R.6800, The Heroes Act; Implementation of H.R.266, Paycheck Protection Program and Health Care Enhancement Act (P.L.116-139); H.R.8337, Continuing Appropriations Act, 2021 and Other Extensions Act.
Client expense: Not reported · Firm income: $50,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Food Industry (safety, labeling, etc.)
H.R. 8179, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020, a bill to to make hemp, cannabidiol derived from hemp, and any other ingredient derived from hemp lawful for use under the Federal Food, Drug, and Cosmetic Act as a dietary ingredient in a dietary supplement; all provisions relating to dietary supplements
Client expense: $70,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Consumer Issues/Safety/Products
Policy initiatives on hemp-derived cannabidiol (CBD), supporting actions that will lead to a legal and regulatory pathway to market for hemp-derived CBD products, pertaining to dietary supplements. H.R. 8179 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020. H.R. 5587 - A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances. S. 2895 - SARMs Control Act of 2019, A bill that would give authority to the Attorney General to schedule SARMs as a controlled substance.
Client expense: $70,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE, Treasury, Dept of
2020 · third_quarter · Food Industry (safety, labeling, etc.)
Canabidiol (CBD) product regulation H.R. 8179, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020 Food recall traceability FDA's "Blueprint for New Era in Food Safety"
Client expense: $150,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Motor Carrier Safety Administration, Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Transportation, Dept of (DOT), Treasury, Dept of
2020 · third_quarter · Health Issues
Issues related to hemp-based cannabidiol (CBD); Food and Drug Administration activity to set standards for food and dietary supplements containing hemp-based CBD; H.R. 5587, a bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances; H.R. 8179, The Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Agriculture
Issues related to hemp-based cannabidiol (CBD); Food and Drug Administration activity to set standards for food and dietary supplements containing hemp-based CBD; H.R. 5587, a bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances; H.R. 8179, The Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Health Issues
HR 8179 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020; provisions related to the federal regulation of CBD
Client expense: $40,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Health Issues
H.R.8179, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020, generally Monitor H.R.7614, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021, Hemp-Derived Cannabidiol (CBD) regulations
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Health Issues
issues relating to the approval of cannabinoids in supplements and food. HR 8179.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Agriculture
Trade agreements and the treatment of tobacco; issues affecting tobacco; industrial hemp and cannabis issues; FDA treatment of tobacco and hemp, H.R.8179.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Food Industry (safety, labeling, etc.)
Hemp-Derived Cannabidiol (CBD) regulations H.R.8179, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020, generally S.4463, A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses, FSA and HSA, Dietary supplement related issues Monitor Regulatory enforcement of dietary supplements
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Alcohol and Drug Abuse
H.R. 1595 - SAFE Banking Act of 2019 (Ed Perlmutter, D-CO-7) , ALL PROVISIONS H.R.1119 - To amend the Controlled Substances Act to reduce the gap between Federal and State marijuana policy, and for other purposes (Earl Blumenauer, D-OR-3) , ALL PROVISIONS H.R.2012 - To amend the Controlled Substances Act to provide that Federal law shall not preempt State law (Diana DeGette, D-CO-1) , ALL PROVISIONS S.2400 - A bill to promote cannabis research, and for other purposes (Dick Durbin, D-IL) , ALL PROVISIONS H.R.3884 - Marijuana Opportunity Reinvestment and Expungement Act of 2019 (Jerrold Nadler, D-NY-10) , ALL PROVISIONS H.R.3884 - To decriminalize and deschedule cannabis, to provide for reinvestment in certain persons adversely impacted by the War on Drugs, to provide for expungement of certain cannabis offenses, and for other purposes (Jerrold Nadler, D-NY-10) , ALL PROVISIONS oSenate version introduced by Kamala Harris, S.2227 H.R.3797 - To amend the Controlled Substances Act to make marijuana accessible for use by qualified marijuana researchers for medical purposes, and for other purposes (Earl Blumenauer, D-OR-3) , ALL PROVISIONS H.R.4322 - Expanding Cannabis Research and Information Act (Donna Shalala, D-FL-27) , ALL PROVISIONS H.R.4323 - Marijuana 1-to-3 Act of 2019 - To provide for the rescheduling of marijuana into schedule III of the Controlled Substances Act (Gregory Steube, R-FL-17) , ALL PROVISIONS S.2979 - A bill to improve drug testing for transportation-related activities (Roger Wicker, R-MS) , ALL PROVISIONS S.3070 - A bill to modify reporting requirements under the Controlled Substances Act (Dianne Feinstein, D-CA) , ALL PROVISIONS S.4386 - A bill to decriminalize and reschedule cannabis, to provide for the regulation of cannabis and cannabis products to protect public health and safety, and for other purposes (Tina Smith, D-MN) , ALL PROVISIONS H.R.8179 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020 (Kurt Schrader, D-OR-5) , ALL PROVISIONS
Client expense: $550,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
2020 · third_quarter · Pharmacy
Pseudoephedrine -- Potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient and oppose PSE restrictions such as a prescription requirement (no bill number). Mandatory recall authority of the FDA Supporting a process within FDA that ensures clarity and timely outcomes for the FDA, applicants and stakeholders, as well as utilizing existing technologies to further streamline the prescription-to-nonprescription switch application process without changing the existing clear distinction between prescription and nonprescription medicines. H.R.3164 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020 S.930 - Allowing Greater Access to Safe and Effective Contraception Act S.1847/H.R. 3296 - Affordability is Access Act S.2522 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020 H.R.6058 - SHOP SAFE Act of 2020 S.3431 - INFORM Consumers Act Legislation to increase domestic production of pharmaceuticals and the domestic supply chain. H.R. 6395 - National Defense Authorization Act for Fiscal Year 2021 S.4049 - National Defense Authorization Act for Fiscal Year 2021 HR 8179 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020
Client expense: $140,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of, Vice President of the U.S.